Mandate

Vinge advises Main Capital and Alfa eCare in connection with the acquisition of Avancit AB

The Alfa eCare group is a recognized and rapidly growing software provider within the e-health sector that offers solutions to both private and public healthcare providers in the Nordics.

Avancit AB is a leading market player in Sweden within business-developing software solutions for personal assistance providers. The company offers services to both smaller and larger companies within several areas of expertise - including system development, implementation, support, training and infrastructure. The acquisition of Avancit AB is the fifth acquisition by the Alfa eCare group since Main Capital became majority owners of the group in 2020.

Vinge’s team advising Main Capital and Alfa eCare consisted of Jonas Johansson, Filip Öhrner, Per Kling, Linus Adolfsson, Sophie Böje, Jonna Skog, Sara Strandberg, Hedvig Ekdahl, Nicklas Thorgerzon and Rebecka Målquist.

 

Related

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026

Vinge has advised Skeptiva AB in connection with its financing round

Skeptiva is developing the next generation of cybersecurity defenses against fraud. The company has developed an AI application that detects attacks and alerts users in real time.
March 11, 2026

Vinge has advised Main Capital in connection with the acquisition of Good Solutions Sweden AB

Good Solutions Sweden AB (”Good Solutions”) provides software that helps factories identify and reduce production losses. The software converts data from machines and operators into insights that can be used to streamline production and increase profitability.
March 11, 2026